Drug Database
Back to search

Japan· JP-3962002F3015

メトホルミン塩酸塩

A metformin product containing メトホルミン塩酸塩, registered in Japan, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

On Japan’s NHI price listATC A10BA02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedメトホルミン塩酸塩ATCA10BA02REGISTER NO.JP-3962002F3015PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about メトホルミン塩酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin is registered in 19 of 19 countries.

Countries holding a registration under ATC A10BA02 (metformin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 11 of them publish a price we can compare per daily dose
Search metformin products by name

Metformin · ATC A10BA02

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of metformin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $0.10 in Spain to $0.52 in Switzerland — a ×5.0 gap.

  • 6 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Metformin · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.52
  • CZ Czechia$0.24
  • IT Italy$0.19
  • FR France$0.17
  • US United States$0.11 (acquisition cost)
  • ES Spain$0.10
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
メトホルミン塩酸塩
Manufacturer
—
Country
Japan (JP)
ATC code
A10BA02
ATC class
Metformin
Defined daily dose
2 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

790 interactions on record for metformin.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin against other medicinesHow interaction checks work

Metformin · interactions on record

790 records

  • 17 severe
  • 353 moderate
  • 45 minor
  • 370 info

Most severe, free to view

  • EthanolB05XX04severe
  • IoxilanV08AB12severe
  • CimetidineA02BA01moderate
  • RanitidineA02BA02moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A10BA02

Metformin, as other registers publish it.

All metformin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be22fa16-7a9e-4da3-8ef0-5c9feb0648eb
GET /v1/drugs/be22fa16-7a9e-4da3-8ef0-5c9feb0648eb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５００ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3962002F3015",
  "category": "内用薬",
  "price_yen": 10.8,
  "generic_name": "メトホルミン塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "3962",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about metformin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console